All terms in DRUGBANK

Label Id Description
Verdinexor DB12207 [Kpt 335 is under investigation in clinical trial NCT02431364 (Trial of Safety and Tolerability of Oral Verdinexor (Verdinexor) in Healthy Adults).]
Iron isomaltoside 1000 DB12208 [Iron isomaltoside 1000 is under investigation in Iron Deficiency Anaemia. Iron isomaltoside 1000 has been investigated for the treatment and basic science of Anemia, Gastric Cancer, Esophageal Cancer, Chronic Kidney Disease, and Anemia, Iron-Deficiency, among others.]
Iodoxamic acid DB13539 [Radiopaque medium used in the diagnosis of gall bladder & bile duct diseases, usually as meglumine salt.]
Remetinostat DB14869 [Remetinostat is under investigation in clinical trial NCT02213861 (Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma).]
PF-03654746 DB12201 [PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome, and Excessive Daytime Sleepiness.]
Cyclopenthiazide DB13532 [Cyclopenthiazide is a thiazide diuretic with antihypertensive properties. In a double blind, randomized crossover study, cyclopenthiazide was effective in reducing diastolic blood pressure in mildly hypertensive non-insulin dependent diabetic patients [A27180]. It is a positive allosteric modulator at AMPA-A receptors [T28].]
Brolucizumab DB14864 [Brolucizumab, also known as RTH258 or ESBA1008,[A187211] is a monoclonal antibody indicated to treat neovascular age related macular degeneration.[L9089] Brolucizumab was granted FDA approval in October 2019.[L9089]]
Zalutumumab DB12202 [Zalutumumab is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). Zalutumumab has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.]
Methylestrenolone DB13533
Amcasertib DB14866 [Amcasertib is under investigation in clinical trial NCT02483247 (A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer).]
Tozadenant DB12203 [Tozadenant has been investigated for the basic science of Cocaine Dependence.]
Gedocarnil DB13534
Terbogrel DB12204 [Terbogrel has been used in trials studying the treatment of Hypertension, Pulmonary.]
Nebacumab DB13535
Human interleukin-2 DB14865 [Human interleukin-2 is under investigation in clinical trial NCT03475134 (TIL-ACT After NMA Chemo With IL-2 and Nivo Rescue in mMEL).]
Ensartinib DB14860 [Ensartinib is under investigation in clinical trial NCT03420508 (Treating Patients With Melanoma and ALK Alterations With Ensartinib).]
PF-06815345 DB14862 [PF-06815345 is under investigation in clinical trial NCT02654899 (Single Dose Study of PF-06815345 in Healthy Subjects).]
Mepindolol DB13530 [Mepindolol is a 2-methyl derivative of pindolol. It is a beta blocker.]
Nicofetamide DB13531
Tivantinib DB12200 [Tivantinib has been investigated in Solid Tumors.]